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Background: To evaluate the effect of the 3D radiation field design on normal tissues compared with commonly
used appositional fields in patients with lumbar spine metastases.
Methods and materials: Ten comparative treatment plans for radiation of lumbar spine metastases were
compared for posterior and anterior- posterior fields with 3D plans.
Results: The PTV coverage in all comparative plans was similar. V 15 of the bowel in 3D, AP-PA and PA plans was
6.7 Gy (SD 6.47), 39.8 Gy (SD 11.4) and 37.3 Gy (SD15.7), respectively (p < 0.0001). The mean dose to both kidneys
was 9.6 Gy (SD 4.8), 4.1 Gy (SD 3.9) and 4.6 Gy (SD 4.4) for appropriate plans (p = 0.002). Maximal dose to the spinal
cord was 30.6 Gy (SD 2.1), 33.1 Gy (SD 9.8) and 37.7 Gy (SD 2) for 3D, AP-PA and PA plans.
Conclusion: 3D conformal treatment planning of lumbar vertebral metastases was significantly better in term of
bowel and spinal cord exposure compared to AP-PA and PA techniques. The exposure of the kidneys in 3D plans,
while greater than in the comparative plans, did not violate accepted dose-volume thresholds.
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Bone metastases constitute a growing oncologic problem
due to increasing life expectancy among cancer patients
[1]. The spine remains one of the most frequently
involved sites for metastatic disease. In one study that
evaluated 832 patients who died of their cancer, verte-
bral involvement was identified in 36% at autopsy [2].
One of the most commonly used approaches to treat
painful bone metastases is external beam radiation ther-
apy. The efficacy of radiation therapy in terms of pain
alleviation ranges between 50–80% [3]. Multiple publica-
tions including randomized studies, meta-analyses and
guidelines have reflected on the best dose and fraction-
ation needed to achieve durable palliation. The most
popular regimens are 30 Gy in 10 fractions or 20 Gy in* Correspondence: slavas2506@yahoo.com
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reproduction in any medium, provided the orfive fractions. A single 8 Gy fraction seems to be as
effective as more protracted schedules [4-6].
Traditional technique for treating metastases of the
spine is titrated to the location of the lesions. In the
lumbar region, typical fields include a single posterior
beam or anterior-posterior (AP-PA) portals, usually
depending on the skin- target distance.
Over the past several decades the external beam irradi-
ation armamentarium has expanded to include con-
formal three - dimensional (3D) radiotherapy, intensity
modified radiation therapy (IMRT) and stereotactic
approaches. Although these methods have been readily
adopted by senior clinicians [7], it is difficult to identify
peer-reviewed articles discussing the advantages of
these new techniques above classical AP-PA or single
posterior-anterior (PA) beam treatment of vertebral col-
umn metastases. Andic et al. analyzed three-dimensional
(3D) data of conventional two- dimensional (2D) pallia-
tive spinal bone irradiation using different referencetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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national Commission on Radiation Units and Measure-
ments (ISRU) Report 50. They concluded that in
palliative spinal bone irradiation, 2D conventional single
posterior field radiotherapy did not comply with the
ICRU Report 50 recommendations for PTV dose distri-
bution, while AP-PA field plans did attain the intended
dose ranges with a homogenous distribution and reason-
able doses to the medulla spinalis, esophagus and intes-
tines [8] However, this relatively recently published
study did not investigate the multiple field arrangements
that might further improve the conformality of treat-
ment Accordingly we were interested in assessing the
relative benefits of several straightforward external beam
approaches for treating spinal metastases with respect to
target volume coverage and the potential influence of
these respective beam arrangements on normal tissue
(e.g., kidneys, small bowel, and spinal cord) tolerance.
Despite the fact that formal comparisons of 3-D tech-
niques with even more traditional techniques (i.e., PA
only, AP-PA) could have been carried out years ago, the
absence of such comparisons in the literature prompted
us to rigorously evaluate this matter. The issue has
assumed greater importance because today, patients with
bone metastases live longer [1] and therefore the oppor-
tunity to manifest delayed complications has become
greater. Moreover, hypofractionated regimes are often
considered in an era where not only stereotactic body
radiation therapy but also intensity modulated radiation
therapy is practiced. As such, large doses are given to
associated organs per fraction with heightened concerns
for late toxicity.
Methods and materials
Patients’ characteristics are presented in Table 1.
Ten comparative plans were evaluated from randomly
chosen patients with lumbar spine metastases who were
treated from 2007 to 2010. Ages ranged from 44–86Table 1 Patients’ characteristics
Treated vertebrae Diagnosis Gender Age Number
L2-L4 Carcinoid Female 60 1
L2-L5 Lung Ca Male 77 2
D10-L2 Lung Ca Male 48 3
D10-L2 Breast Ca Female 44 4
L1-L3 Prostate Ca Male 83 5
L1-L5 Breast Ca Female 70 6
L1-L3 Prostate Ca Male 76 7
L3-L5 Lung ca Male 77 8
L1-L4 Prostate Ca Male 87 9
L1-S1 Lung Male 71 10
The table depicts patients’ demographic characteristics.(median 74). There were 4 women and six men. The
distribution of primary tumors included three patients
with lung cancer, three men with prostate cancer, two
women with breast cancer, one patient with colorectal
cancer as well as one individual with gastric cancer.Planning approaches
Every patient underwent CT simulation on a Big Bore
CT unit (Philips, Eindhoven, Netherlands) with 3 mm
slices. All patients were placed in the supine position
with arms above the head. The gross tumor volume
(GTV) was delineated in accordance with the visible
lesions on imaging studies. A normal appearing vertebral
body above and below the radiographic abnormality was
encompassed to generate the clinical treatment volume
(CTV). The planning treatment volume (PTV) included
an additional 5–10 mm around the CTV in deference to
multi-leaf collimator constrants and daily position in-
accuracy. The upper and lower margins of PTV were
limited at the intervertebral disc spaces. Critical organs
(kidneys, spinal cord and bowel) were delineated separ-
ately. Bowel loops were easily identified on each slide ra-
ther than delineating the whole abdominal cavity.
Patients were immobilized using a standard laser system.
Total doses of 30 Gy in 3 Gy fractions were prescribed
to the point located at the center of the PTV that is in
accordance with the ICRU 50. The energy of X rays was
6 or 18 MV or their combinations depending on the
depth of the isocenter.
A series of plans (i.e., PA, AP-PA and 3D) was
assessed for each patient. Representation of 3D con-
formal, AP-PA and PA plans for a typical patient is
depicted in Figure 1. The three-dimensional con-
formal plan consisted of 2 posterior wedged oblique
beams of 120–140 and 220–240 degrees on each side
as well as one posterior beam. The data were col-
lected for CTV coverage, mean dose and V15 expos-
ure of the bowel, mean dose for both kidneys and
maximal dose of the spinal cord for every patient in
all comparative plans. All above mentioned para-
meters were calculated for their mean values for the
patients in the study. The best available plan was
selected for treatment. Verification set up films were
taken prior to the initiation of treatment.Statistical considerations
A comparison of group means of all the parameters was
performed using a one-way analysis of variance. The
Multiple comparison adjustment method “GT2” by
Hochberg [9] was employed to determine significant dif-
ferences between pairs of groups. SAS for Windows ver-
sion 9.2 was used for the analysis.
Figure 1 PA, AP-PA and 3D conformal plans for a typical patient. Three representative plans are displayed in axial view for 3D conformal,
AP-PA and PA beams technique.
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Three representative plans are displayed in axial view for
3D conformal, AP-PA and PA beams technique
(Figure 1). Dose volume histograms for CTV and bowel
are represented in Figure 2. It can be seen that the CTV
coverage is similar for all 3 plans while there is improved
bowel sparing in the 3D plan. 95% of the prescribed dose
of 30 Gy in 10 fractions covered the CTV in all com-
parative plans. Dose variations between + 7% and –5%
were not exceeded in any plan and hot spot above these
limits were not allowed. DVH of the spinal cord and kid-
neys is represented in Figure 3. It is evident that the 3D
plan offers improvement in maximal dose deposited to
the spinal cord while maintaining the kidney dose within
tolerable limits. The V 15 of the bowel in 3D, AP-PA
and PA plans were as follow 6.7% (SD 6.47), 39.8% (SD
11.4) and 37.3% (SD15.7), respectively (p < 0.0001).
(Figure 4) These histograms show that the best V15 is
achievable with the 3D conformal plan. Mean dose to
the bowel was 8.7 Gy (SD 2.2), 11.6 Gy (SD 3.2) and
9.2 Gy (SD 3) (p < 0.0003) for the respective beam
arrangements (Figure 5). These histograms show that
the best mean dose to the bowel is associated with the
3D conformal plan. The mean dose to both kidneys was
9.6 Gy (SD 4.8), 4.1 Gy (SD 3.9) and 4.6 Gy (SD 4.4) for
these respective plans (p = 0.009). The maximal dose to
the spinal cord was 30.6 Gy (SD 2.1), 33.1 Gy (SD 9.8)
and 37.7 Gy (SD 2) for 3D, AP-PA and PA plans,
respectively (Figure 6). These histograms show that the
lowest maximal spinal cord dose is achievable with the
3D conformal plan. The radiation exposure to critical
organs is presented in Additional file 1.
Discussion
Irradiation has constituted a traditional therapeutic op-
tion for palliation of lumbar metastases. Historically, ex-
tensive research has explored optimal dose-fractionationrelationships for his modality. However, despite the
modern revolution in treatment planning there is limited
information on sophisticated field configuration for the
irradiation of the lumbar spine. Our results indicate that
similar PTV coverage can be achieved in the three com-
parative plans selected but that the optimal dose distri-
bution is associated with the 3-D plan which was
developed.
Approximately 70% of cancer patients have metastatic
disease at death. The spine is involved in up to 40% of
those patients. Spinal cord compression may develop in
5% to 10% of cancer patients and up to 40% of patients
with preexisting nonspinal bone metastasis (>25,000
cases/y). Given the increasing survival times of patients
with cancer, greater numbers of patients are likely to de-
velop this complication [10]. Such lesions are most fre-
quently encountered in the management of patients
diagnosed with cancers of the breast and prostate.
Patients with bone metastases that arise from the latter
two primary malignancies can enjoy median survival
times that are measured in years while mean survival
times as low as 6 months from bronchogenic carcinoma
are seen in contemporary series [11].
External beam irradiation constitutes a time-honored
intervention for the treatment of bone metastases;
especially those situated in the spine. Controversies
surrounding dose fractionation schedules for bone me-
tastases have preoccupied radiation oncologists for years
[12]. Not only retrospective series but also numerous
randomized controlled clinical trials have stated that
similar pain relief outcomes are achievable with short
and long course of radiotherapy. Prescriptions for radi-
ation treatment, however, require more specification
than the delineation of dosage, beam energy and nota-
tion of total and fractional dose.
Despite the abundance of information regarding dose-
fractionation regimens for spinal metastases, limited data
Figure 2 Dose volume histograms for PTV and bowel. It can be seen that the CTV coverage is similar for all 3 plans while there is improved
bowel sparing in the 3D plan.
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the treatment of the spine [13]. Although sophisticated
approaches such as stereotactic body irradiation for
spinal metastases have been readily adopted by many
institutions [14] such technologies are not available to
all users around the world. Therefore, a formal assess-
ment must be made of more accessible technologies.
Radiation oncologists have always concerned them-
selves with both components that comprise the “thera-
peutic index”. Our data underscore the value of the 3D
conformal approach for spinal metastases as a palliative
tool. When treating the lumbar spine; however, severalorgans are at a risk for expressing radiation-related dam-
age. In term of anticipated acute small bowel toxicity
Baglan et al. showed that irradiation of more than 15 Gy
to at least 150 cm3 is associated with an incidence of
grade 3 acute small bowel toxicity approximating 30%
using the Common Toxicity Criteria scale [15,16]. The
mean radiation dose at which diarrhea grade 2–3 oc-
curred was 27 Gy according to Gunnlaugsson A et al.
[17]. Comprehensive review of the radiation dose- vol-
ume effects in small bowel was published by Kavanagh
et al. in 2010 [18]. According to those authors, following
doses on the order of 50 Gy, late small-bowel
Spinal cord
Kidneys (right and left)
Figure 3 Dose volume histogram of the spinal cord and kidneys. It is evident that the 3D plan offers improvement in maximal dose
deposited to the spinal cord while maintaining the kidney dose within tolerable limits.
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observed after partial organ irradiation. A dose of 25 Gy
in five fractions of preoperative radiation therapy is asso-
ciated with the same rate of late toxicity. It was also
underscored in the review that small bowel obstruction
occurred in 30% when fields were extended to the level
of L1 or L2 versus 9% with pelvic- only therapeutic strat-
egies [16]. Reports on the probability of the late small
bowel damage could not be identified in correlation with
the radiation dose- volume function. Notwithstanding,
we reasoned that maximum effort should be invested tospare as much small bowel from the radiation field as
possible. As a surrogate, we reported in our study the
mean volume of the bowel irradiated and V15.
It must be acknowledged that one of the possible dis-
advantages in conformal 3D radiation techniques which
employ a paired set of oblique wedged fields is the de-
position of higher doses within the kidneys. The risks of
radiation damage to the kidneys were comprehensively
summarized by Dawson et al. The dose associated with a
5% risk for toxicity at 5 years was 18–23 Gy regardless
of the fractionation scheme used [19]. It was within the
Figure 4 V 15 of the bowel in 3D, AP-PA and PA plans. These histograms show that the best V15 is achievable with the 3D conformal plan.
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tive assessment of potential renal damage from radiation
treatment.
Although the beam arrangements evaluated herein
were not associated with optimal renal sparing, the dose
volume histograms which paid attention to the kidney
suggest that such treatments can be delivered without
inducing nephropathy [18]. Moreover, vis-à-vis other
adjacent critical organs (e.g., bowel, spinal cord) the con-
formal approach offered significant improvement. AsFigure 5 Mean dose to the bowel. These histograms show that the bestindicated, none of the 3 approaches evaluated was asso-
ciated with advantages in terms of target coverage.
A recently published trial by the RTOG (97–14)
assessed quality of life endpoints among patients suffer-
ing from bone metastases [20,21]. As predicted, radi-
ation therapy was highly effective in reducing bone pain.
The framers of the protocol allowed physicians to treat
patients who presented with spinal metastases via AP-
PA or posterior-only portals. Despite the availability of
conformal approaches during the recruitment period ofmean dose to the bowel is associated with the 3D conformal plan.
Figure 6 Maximal dose to the spinal cord. These histograms show that the lowest maximal spinal cord dose is achievable with the 3D
conformal plan.
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an option. While this decision may have successfully iso-
lated the dose fractionation question (i.e., by eliminating
the variability in radiation treatment approaches) it is
possible that patients enrolled in the study were
impacted upon from a QOL perspective due to the use
of non-optimized portal arrangements.
The RTOG is about to open the phase III component
of protocol l 06–31 which will randomize patients diag-
nosed with bone metastases between SBRT and other
forms of external beam radiation therapy. While the
protocol does stipulate [22] that for those randomized to
the conventional treatment arm “field arrangements to
treat the target lesion may be chosen at the discretion of
the treating radiation oncologist” the study goes on to
provide detailed suggestions for treating the spine via 2-
field approaches (AP-PA for thoraco-lumbar spine; lat-
eral beams for cervical spine) with only cursory mention
of the possibility of using oblique beams.
The absence of rigorous comparisons of portal selec-
tion is also evident in reference textbooks [13] as well as
the recent evidence-based ASTRO guidelines on pallia-
tive radiotherapy for bone metastases [6] which provide
extensive information on dose volume relationships but
fail to bring up the matter of optimal field arrangements
when conventional irradiation is employed. The reality is
that 3D conformal RT is already the standard procedure
for irradiation in many institutions worldwide. However,
even in the most recently published update of the Inter-
national Consensus on palliative RT endpoints for future
clinical trials in bone metastases opinion was split be-
tween prescribing the dose to the mid-vertebral body oranterior vertebral body for a single direct field and the
guidelines for conformal radiotherapy and stereotactic
radiotherapy were subsumed under the rubric of “future
research areas” [23]. Ironically, the same guidelines de-
vote extensive space towards consideration of SBRT
techniques despite the fact that the use of the latter is
not yet justifiable with level 1 evidence. Since the
authors of these guidelines do not yet consider SBRT to
be a standard of care, we believe that data must still be
collected regarding the merits of modern as well as con-
ventional beam arrangements.
It is troubling to reflect on the current reality of
extremes. Today’s clinician seems to be left with polar-
ized options for treating bone metastases of the spine.
Specifically, physicians can avail themselves of the most
modern variants of SBRT; however, there are certainly
many palliative cases which do not require this level of
sophistication. Conversely, alternative options that are
documented in the literature include the most rudimen-
tary radiation techniques (i.e. Posterior beams or com-
bination of AP and PA fields). The rationale for
presenting our results is to re-orient the clinician to an
intermediate level of sophistication in the palliative ap-
proach to this entity.
Conclusions
In summary, 3D conformal radiation treatment of lum-
bar vertebral metastases was significantly better in term
of bowel and spinal cord exposure when compared to
AP-PA and PA techniques. The routine deployment
of stereotactic body radiation therapy and intensity
modulated radiation therapy for management of bone
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resources. Clinicians should therefore continue to avail
themselves of 3D conformal approaches as dictated by
the complexity of the clinical case being evaluated.
Additional file
Additional file 1: Table S1. Critical organs radiation exposure. The
table depicts an exposure of kidneys, spinal cord and small bowel to
radiation.
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